Precision Medicine in Oncology® Sarcomas Supportive Care Spotlight - In-person and virtual events just for HCPs CME Opportunities Choose Specialty Research will also need to focus on the optimal duration of T-DXd therapy before transitioning to ma...
Precision Medicine in Oncology® Sarcomas Supportive Care Spotlight - In-person and virtual events just for HCPs CME Opportunities Choose Specialty At a median follow-up of 14.7 months for the overall population in cohort A, the median progression-free survival (PFS) and overall survi...
The clinical trial transparency in oncology significantly increased over the recent years Seung Yeon Song, Eun Young Kim Prevalence and associated factors of influenza vaccination coverage in Korean adults with cardiovascular disease. Eun Young Kim, Jae Ho Ko, Young Saing Kim, Pyung Chun Oh Does the...
Sloan An independently validated nomogram for individualized estimation of survival among patients with newly diagnosed glioblastoma: NRG Oncology RTOG 0525 and 0825. Haley Gittleman, Daniel Lim, Michael W Kattan, Arnab Chakravarti, Mark R Gilbert, Andrew B Lassman, Simon S Lo, Mitchell Machtay, ...
Head and Neck Oncology Team News Congratulations to Senta Clinic Chief of Plastic Surgery Dr. Jason Toranto for a tremendous data driven talk... Read More → Dr. Mansfield Joins the Editorial Board of Acta Scientific Dr. Perry Mansfield joins the prestigious editorial board of the International ...
An anti-DR5 antibody-curcumin conjugate for the enhanced clearance of activated hepatic stellate cellsVan Quy Nguyen aDong Gil You aChan Ho Kim aSeunglee Kwon aWooram Um aByeong Hoon Oh aJae Yoon An aJueun Jeon aJae Hyung Park a b...
because the Cox PHM has not found any significant predictors for the LC, where significance is assessed using an F-test. In other words, any calculated c-index, in this case, is not reliable and can be the result of a random model. The c-index is not necessarily an indicator of the ...
express concern that we exclude cT3 disease and prostate-specific antigen (PSA) values > 26, they highlight an important point: in the era of Radiation Therapy Oncology Group 9413 and the RF, these findings were more commonplace (5–6% of patients) (3, 6) , whereas in the contemporary ...
MB Horowitz,PD Purdy - 《Oncology》 被引量: 66发表: 2004年 Expression of the MCP-1 Gene and the HPV 16 E6/E7 Oncogenes in Squamous Cell Carcinomas of the Cervix uteri and Metastases Monocyte chemoattractant protein 1 (MCP-1) plays an important role in the recruitment of monocytes in sol...
Byoung Chol Cho, MD, PhD, professor, internal medicine, Division of Medical Oncology, Yonsei Cancer Center, Yonsei University College of Medicine, discusses efficacy and safety findings from the phase 1 CHRYSALIS-2 trial (NCT04077463) evaluating amivantamab-vmjw (Rybrevant) in combination with laze...